Propofol
Approved · FDAAlso known as Diprivan, Propovan, Propoven, Propoflo+3 more
Diprivan, Propovan, Propoven, Propoflo, 2,6-Diisopropylphenol, 2,6-bis(1-methylethyl)phenol, Propofolum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Approval: PROPOFOL (ANDA220857)
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration (SERENE)
Propofol interruption of ECT seizure to reduce side-effects: a pilot study.
Use of an EEG-bispectral closed-loop delivery system for administering propofol.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Data from the U.S. Food and Drug Administration (U.S. Food and Drug Administration), public domain (CC0).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes6
Journals, researchers & institutions
- Academic emergency medicine : official journal of the Society for Academic Emergency Medicine1
- Acta anaesthesiologica Scandinavica1
- Paediatric anaesthesia1
- Psychiatry research1
- Giesecke AH1
- Glynn S1
- Gray RO1
- Gunter J1
- Ho JD1
- Hoffmann C1
- Hossain MM1
- Kibelbek MJ1
- Cincinnati Children's Hospital Medical Center1
- Cincinnati Children's Medical Center1
- Hennepin County Medical Center1
- Loma Linda University1
- University of Hirosaki School of Medicine1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.